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Background: There is evidence to suggest that delivery of diabetes self-management support by diabetes
educators in primary care may improve patient care processes and patient clinical outcomes; however, the
evaluation of such a model in primary care is nonexistent in Canada. This article describes the design for the
evaluation of the implementation of Mobile Diabetes Education Teams (MDETs) in primary care settings in Canada.
Methods/design: This study will use a non-blinded, cluster-randomized controlled trial stepped wedge design to
evaluate the Mobile Diabetes Education Teams' intervention in improving patient clinical and care process outcomes.
A total of 1,200 patient charts at participating primary care sites will be reviewed for data extraction. Eligible patients
will be those aged ≥18, who have type 2 diabetes and a hemoglobin A1c (HbA1c) of ≥8%. Clusters (that is, primary
care sites) will be randomized to the intervention and control group using a block randomization procedure within
practice size as the blocking factor. A stepped wedge design will be used to sequentially roll out the intervention so
that all clusters eventually receive the intervention.
The time at which each cluster begins the intervention is randomized to one of the four roll out periods (0, 6, 12, and
18 months). Clusters that are randomized into the intervention later will act as the control for those receiving the
intervention earlier. The primary outcome measure will be the difference in the proportion of patients who achieve the
recommended HbA1c target of ≤7% between intervention and control groups. Qualitative work (in-depth interviews
with primary care physicians, MDET educators and patients; and MDET educators’ field notes and debriefing sessions)
will be undertaken to assess the implementation process and effectiveness of the MDET intervention.
Trial registration: ClinicalTrials.gov NCT01553266
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Diabetes mellitus is a chronic illness that requires a life-
long commitment to complex lifestyle modifications in-
volving nutrition management, a physically active
lifestyle, regular self-monitoring of blood glucose and
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reproduction in any medium, provided the ormanagement of these lifestyle modifications have been
shown to reduce the risk and progression of diabetes
complications [1-6]. Achieving and sustaining effective
management is challenging; more than half of those
living with diabetes in Canada are unable to meet
the recommended target for glycemic control (≤7%
hemoglobin A1c (HbA1c)) [7]. As a result, diabetes self-
management support (DSMS) is recommended by
Canadian clinical practice guidelines for the management
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of their illness [8].
DSMS is a collaborative process through which people
with, or at risk for, diabetes gain the knowledge and
skills needed to modify behavior and successfully self-
manage the disease and its related conditions. It is an
interactive, ongoing process involving the person with
diabetes (and possibly the caregiver and/or family) and a
diabetes educator(s), and focuses on essential self-care
behaviors, such as healthy eating, being active, monitor-
ing blood glucose, taking medication, problem solving,
healthy coping and reducing risks of further complica-
tions [9]. DSMS primarily relies on patients and diabetes
educators to define management issues, set priorities, es-
tablish collaborative goals, identify barriers, create a
management plan and problem-solve to maintain opti-
mal management [10,11]. The few studies that exist on
the delivery of DSMS in primary care have found that
DSMS has numerous benefits on patient clinical and
care process outcomes, such as an improvement in pa-
tient knowledge [12-14]; a reduction in body weight
[13], HbA1c [12-16], cholesterol [14-17], fasting blood
glucose [13,18], self-blood glucose monitoring [16] and
blood pressure [18]; and improved primary care phys-
ician (PCP) adherence to diabetes clinical practice guide-
lines [14,17]. However, none of these studies have been
conducted within a Canadian setting.
Many diabetes education programs (DEPs) across On-
tario and Canada are starting to provide outreach ser-
vices by creating collaborative partnerships with local
PCPs, and establishing mobile diabetes education teams
(MDETs) that deliver DSMS to patients and provide dia-
betes training and support to PCPs within primary care
sites. Models of care that integrate multidisciplinary
teams have been shown to improve patient access to
DSMS [19] and increase physician support to reduce
clinical inertia in the area of diabetes management in
primary care [20-24]. Furthermore, there is growing
evidence that inter-professional collaboration (IPC),
whereby professionals from different health disciplines
collaborate together to achieve a shared goal, such as
quality patient care [25], can improve patient care pro-
cesses and health outcomes [26-42]. Thus, to manage
diabetes effectively, alternative models of practice that
integrate inter-professional teams may be required to re-
duce the burden of diabetes.
This protocol is for the evaluation of the implementa-
tion of MDETs in primary care in Canada. This model
of practice supports PCPs at various primary care sites
to assist in and share the care and management of
patients with diabetes by offering a MDET (one regis-
tered nurse (RN) and one registered dietitian (RD))
onsite, one to four times a month based on patient vol-
ume (see Table 1 for an overview of the MDETintervention). The proposed MDET intervention is
informed by the five components of the Chronic Care
Model (CCM) [19]: (i) Organization of integrative pa-
tient health care; (ii) Forming community linkages; (iii)
Encouraging self-management support; (iv) Providing
decision support; and (v) Delivery system redesign (see
Table 2). This article describes the non-blinded, cluster-
randomized trial stepped wedge design used in the
three-year evaluation study of the MDET intervention in
primary care.
Aims of the study
The objectives of this study (see Table 2) are to evaluate
the effect of MDETs on: 1)patient clinical outcomes; 2)
the quality of care delivered to patients; and 3) PCPs’
referrals to and patients’ utilization of DEPs. We will
also be examining the implementation process of the
MDETs and the degree of IPC that occurs between PCPs
and MDETs across primary care sites.
Scientific hypothesis
We hypothesize that the MDET intervention results in
the following outcomes at 12 months:
(i) An improvement in patient clinical outcomes,
primarily an increase, or greater proportion, of
patients in the intervention group who are at target
for HbA1c (≤7%) compared to patients in the
control group.(Secondary hypothesis: an increase,
or greater proportion, of patients in the
intervention group who are at target for
low-density lipoprotein (LDL-C) ≤2.0 mmol/L, total
cholesterol-high density lipoprotein ratio (TC-HDL
ratio) < 4.0, and blood pressure ≤ 130/80 mmHg,
compared to patients in the control group).
(ii) An increase in the proportion of PCPs performing
patient care processes, according to the Canadian
clinical practice guidelines for the management of
diabetes, in the intervention group compared to the
control group.
(iii) An increase in the proportion of referrals to and
patients’ utilization of DEPs in the intervention




The MDETs in primary care sites, including independent
practices, family health teams, walk-in clinics and com-
munity healthcare centers, will take place in several sub-
urban cities and towns in Ontario. The region’s
population is one of the largest with more than one mil-
lion residents.
Table 1 Mobile Diabetes Education Team (MDET) intervention components, timelines and content
Intervention component Timelines Content
RN initial visit Patient’s first visit
with RN, one hour
Assessment: Time-span with diabetes; diabetes knowledge; recent hospital
admissions; medication regime and adherence; lab blood work review;
medical history; blood pressure; foot exam; capacity for SBGM and/or results
review; current exercise regime; presence of diabetes complications;
risk management for new and existing acute and long-term complications;
proper identification of diabetes.
Education: What is diabetes?; how medications work; signs and symptoms
of high and low blood sugars; how to reduce long-term complications;
benefits of exercise; SBGM technique and timing; how to interpret SBGM
results; sharps disposal; stress management; foot care.
Teach as needed: Insulin time action; insulin administration and technique;
titrating doses; sick day management; travel glucagon and ketones.
RD initial visit Patient’s first visit
with RD,
one hour
Assessment: Effects of food, exercise and medications on blood glucose
levels and cholesterol; lab blood work review; weight history and goals;
fast food consumption; meal composition and timing; specialty foods,
supplements, and alcohol use; food allergies; disordered eating.
Education: Healthy eating guidelines; meal planning, food choices
and portion size; carbohydrate load and consistency; major food nutrients;
specialty food and sweeteners; fiber, fats, sodium, and alcohol; eating out.
Teach as needed: Carbohydrate counting; glycemic index; insulin
carbohydrate ratio.
Action plan and goal setting At initial MDET visits,
and ongoing
MDET helps patient find behaviors they would like to initiate or change;
patient and MDET collaboratively create action plan and set goals. This may
include a referral to a local DEP for additional support (for example, cooking






MDET communicates with PCP through face-to-face meetings or using a
communication tool to review major obstacles to good diabetes control
and make recommendations about medication changes to help improve
control for the patient. Goals are decided upon by the patient as what
they would like to work on before the next visit, and are reinforced by
the PCP on following visits.
MDET follow-up visits 30 minutes x 3 visits over
1-year period
Assessment: Patients’ success in achieving established goals; future
goals; SBGM results and recent blood work to determine diabetes control;
effectiveness of medication and lifestyle changes.
Education: Teach topics listed in RN and RD initial visit guidelines,
based on identified issues from first initial visit, patient questions
and follow-up assessment.
DEP, Diabetes education program; MDET, Mobile Diabetes Education Team; PCP, Primary care physician; RD, Registered dietician; RN, Registered nurse; SBGM, Self
blood glucose monitoring.
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The study involves two groups of participants: PCPs and
patients assigned to their care. PCPs will be selected if
they agree to refer patients with type 2 diabetes to the
MDET. Patients will be included if they are ≥18 years of
age, have type 2 diabetes and have an HbA1c of ≥8%.
Patients who are newly diagnosed or have lived with the
disease for many years are eligible because the primary
treatment/management goal is to achieve glycemic con-
trol and other clinical targets to reduce the risk of com-
plications. As such, we plan to include both prevalent
and incident cases, but restrict inclusion only to patients
who are at high risk (≥8%) in our research sample.
Patients who have a type of diabetes that requires in-
tense and specialized treatment, such as type 1 diabetes,
gestational diabetes or patients on a complex multiple
daily insulin regime, will be excluded. Ethical approvalfor this study has been granted by the Ryerson Univer-
sity Research Ethics Board, including the waiver of con-
sent to review patient medical charts. Informed consent
for all other data collection activities will be gained from
all participants.
Experimental study design
A non-blinded, cluster-randomized trial stepped wedge
design will be used (see Table 3). Findings from such a
study design have been shown to generate sound scien-
tific evidence and may better facilitate the implementa-
tion of complex health interventions in practice [43].
We propose to randomize clusters (that is, primary care
sites) and not individuals to the intervention and control
group in order to minimize contamination or treatment
dissemination between study groups (intervention or
control). The presence of a MDET is hypothesized to
Table 2 Chronic Care Model – conceptual framework for MDETs in primary care
CCM component Operationalization of CCM components Research objective(s)
Organized integrated
patient care
• Diabetes self-management support is being
offered in PCPs’ offices for patients with diabetes.
i. Examine the effect of MDETs on patient
clinical outcomes.
• An opportunity is created to promote knowledge
exchange and capacity between PCPs and MDETs/DEPs
by working together to provide better care for
patients in primary care.
ii. Evaluate the effect of MDETs on the quality of
care delivered to patients by PCPs.
iii. Examine the effect of MDETs on physician
referral and patient utilization of DEPs.
iv. Assess the implementation process of the
MDET and the degree of IPC between PCPs
and MDETs across primary care sites.
Community linkages • An opportunity is created to promote knowledge
exchange and capacity between PCPs and MDETs/DEPs
by working together to provide better care for
patients in primary care.
iii. Examine the effect of MDETs on physician
referral and patient utilization of DEPs.
iv. Assess the implementation process of the MDET
and the degree of IPC between PCPs and MDETs
across primary care sites.
Patient self-management
support
• Diabetes self-management support is being offered
in PCPs’ offices for patients with diabetes.
i. Examine the effect of MDETs on patient
clinical outcomes.
Provider decision support • An opportunity is created to promote knowledge
exchange and capacity between PCPs and MDETs
by working together to provide better care for
patients in primary care.
i. Examine the effect of MDETs on patient
clinical outcomes.
• A communication tool will be used to exchange
patient recommendations and
treatment plans between MDETs and PCPs.
ii. Evaluate the effect of MDETs on the quality
of care delivered to patients by PCPs.
• Regular case conferences have been agreed upon
between MDETs and PCPs after patients’ visits.
iii. Examine the effect of MDETs on physician
referral and patient utilization of DEPs.
• Hard copy of clinical practice guidelines and Diabetes
Flow Sheet for Diabetes Management for PCPs.
iv. Assess the implementation process of the MDET
and the degree of IPC between PCPs and MDETs
across primary care sites
Delivery system re-design • Diabetes self-management support is being offered
in PCPs’ offices for patients with diabetes.
i. Examine the effect of MDETs on patient
clinical outcomes.
• An opportunity is created to promote knowledge
exchange and capacity between PCPs and MDETs/DEPs
by working together to provide better care for
patients in primary care.
ii. Evaluate the effect of MDETs on the quality
of care delivered to patients by PCPs.
iii. Examine the effect of MDETs on physician
referral and patient utilization of DEPs.
iv. Assess the implementation process of the
MDET and the degree of IPC between PCPs
and MDETs across primary care sites.
DEP, Diabetes education program; IPC, Inter-professional collaboration; MDET, Mobile Diabetes Education Team; PCP, Primary care physician.
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care patients receive within the same practice site.
Because all PCPs who expressed an interest in this
study are eager to have a MDET on site, we plan to use
a stepped wedge design to sequentially roll out theTable 3 Study design – cluster randomized control trial stepp
Randomization of clusters Time 1 Time 2
0 months* 6 months
Cluster 1 1 1
Cluster 2 0 1
Cluster 3 0 0
Cluster 4 0 0
“*” represents baseline data collection across all sites prior to cluster 1 starting the
“0” represents control or existing treatment/standard care at primary care sites; “1”
point.intervention. The time at which each cluster begins the
intervention is randomized to one of the four roll-out
periods (0, 6, 12, and 18 months). The randomization
times are separated by six months to allow for assess-
ment of the primary outcome (that is, HbA1c) within aed wedge design treatment schedules
Time 3 Time 4 Time 5






represents the MDET intervention; each column represents a data collection
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[13]. Clusters that are randomized into the intervention
later will act as the control for the clusters who receive
the intervention earlier. All clusters will subsequently re-
ceive the intervention, providing additional evidence
of the intervention’s effectiveness. Using computer-
generated random numbers, the team statistician blinded
to the identity of the sites will randomize sites using a
block randomization procedure within practice size
(determined by the number of PCPs practicing at each
site) as the blocking factor. Blocking on practice size will
ensure that this site characteristic will be equally distrib-
uted across study groups. For the clusters receiving the
intervention in the first year, 6 and 12 months of follow-
up data collection have been built into the study design
(18 and 24 months) to assess the sustainability of the
intervention and its effects. See Table 4 for an overview
of data collection outcome measures, methods, partici-
pants and timelines.
Quantitative data collection
A repeated cross-sectional survey of patients’ medical
charts will be carried out at all sites at five time intervals
(0, 6, 12, 18 and 24 months). This survey entails ran-
domly selecting charts of eligible patients who received
primary care at the participating site at the time of the
survey. This results in different patients being included
at the five time points. Therefore, data on the demo-
graphic and clinical profile of patients will be obtained
and controlled statistically prior to performing outcome
comparisons between study groups. In the control sites,
a 12-month retrospective data extraction will also be
performed for each patient chart selected. In the inter-
vention sites, a 12-month retrospective data extraction
will be performed prior to the start of the intervention
and up to 12 months during the intervention for each
patient chart selected. This will be conducted to assess
changes in patient care processes and clinical outcomes.
Data will be collected on:
1. Baseline demographic and clinical information (that
is, age, sex, duration of diabetes, smoking status,
comorbidity);
2. Treatment modality (that is, diet, oral agents, insulin,
or insulin with oral agents), medical treatment,
duration of insulin therapy;
3. Frequency and outcomes of tests or measures of
HbA1c, LDL-C, TC-HDL; high density lipoprotein
(HDL-C), diastolic and systolic blood pressure,
glomerular filtration rate (eGFR), albumin/creatinine
ratio (ACR), waist circumference, and weight.
The data will be extracted from patient charts for
baseline comparisons between randomized clusters. Forour primary hypothesis, we will collect HbA1c to assess
the proportion of patients who achieve the recom-
mended target for HbA1c (that is, HbA1C ≤7%) and as-
sess change within patients in the intervention and
between cluster groups. For our secondary hypothesis
we will collect LDL-C, TC-HDL, and diastolic and sys-
tolic blood pressure to assess achievement of each of the
recommended clinical targets (LDL-C <2.0 mmol/L, TC-
HDL ratio < 4.0 and blood pressure <130/80 mmHg) and
assess change within patients in the intervention and be-
tween cluster groups.
The proportion of patient care processes completed
by PCPs over a one-year period (that is, the percentage
of patients with tests for HbA1c, blood pressure, lipid
profile, screening for nephropathy (ACR and eGFR),
foot exams, referrals for dilated retinal exams, and pro-
visions for or recommendations of the flu vaccine)
according to clinical practice guidelines will also be col-
lected from patient charts and compared across study
groups. We also plan to document and descriptively
examine changes to medication (that is, change in drug,
drug dose, and addition of another drug) to assess in-
tensification of medical management and whether the
diabetes educators had an influence on PCP practices.
Descriptive information (that is, sex, age, years prac-
ticing) will be collected for each PCP to further assess
differences in patient care processes between study
groups.
We will also calculate the percentage of patient refer-
rals by PCPs to hosting DEPs and the onsite MDET and
compare this to patients’ actual attendance at DEPs and
scheduled MDET appointments. The referral rate to
DEPs will be compared to the percentage of referrals
from participating PCPs and their patients’ attendance at
DEPs a year prior to the start of the intervention. Char-
acteristics available in patient medical charts (that is,
sex, age, duration of diabetes, clinical information and
so on) will be reviewed and compared between those
who were and were not referred to the MDET to better
understand PCP referral practices. The number of
MDET appointments planned for each patient and the
number of MDET visits attended will be collected during
the intervention period to examine uptake of the MDET
intervention.
Various characteristics of team collaboration will be
measured using the Collaborative Practice Assessment
Tool (CPAT) Version 2 [27] (Office of Interprofessional
Education and Practice, Queen’s University, Kingston,
Ontario Canada). The CPAT survey includes 56 items
across 9 domains, including mission and goals; relation-
ships; leadership; roles, responsibilities, and autonomy;
communication; decision making; conflict resolution;
community linkages and coordination; and perceived ef-
fectiveness and patient involvement, which are scored 1
Table 4 Data collection outcome measures, methods, participants and timelines of evaluation study
Outcome measures Data collection method Participants and timelines
Patient clinical outcome measures
Demographic and clinical information
(age, sex, duration of diabetes, smoking
status, comorbidity)
Patient chart data extraction 20 different randomly-selected
patient charts per site, per time
interval (0, 6, 12, 18 and
24 months of intervention)
Hemoglobin A1c (HbA1c)
Low-density lipoprotein (LDL-C)
Total cholesterol-high density lipoprotein
ratio (TC-HDL ratio)
High density lipoprotein (HDL-C)
Diastolic blood pressure (DBP)
Systolic blood pressure (SBP)




Body mass index (BMI)
Treatment modality
Primary care physician (PCP) patient care process measures
HbA1c, blood pressure, lipid profile, nephropathy
screening (ACR and eGFR) and foot exams/tests
Patient chart data extraction 20 different randomly-selected patient
charts per site, per time interval (0, 6, 12,
18 and 24 months of intervention)
Referrals for dilated retinal exam




PCP questionnaire on descriptive
information (that is, sex, age, years
practicing, type of practice, number
of diabetes patients seen per month)
All PCPs, once
Patients’ experiences and views regarding Mobile
Diabetes Education Team (MDET) intervention
effectiveness
Patient in-depth interviews 20 randomly-selected patients at
12 months of intervention across sites
Scheduled and attended MDET appointments Diabetes education program
charts/forms
All MDET patients, up to
2 years of intervention
Diabetes education program (DEP) utilization outcome measures
PCP referrals to DEPs Diabetes education program charts All patients, 12 months prior to start of
intervention to 12 months following
start of interventionPatients’ utilization of DEPs
Inter-professional collaboration (IPC) and implementation process outcome measures
Collaborative Practice Assessment Tool (CPAT)
scores of PCPs and MDET educators
CPAT All PCPs at 12 months of intervention
All educators at 12 months of intervention
PCPs’ experiences and views regarding the MDET
intervention implementation and IPC
PCP in-depth interviews 16 randomly-selected PCPs at 12 months
of intervention across sites
MDET educators’ experiences and views regarding
the MDET intervention implementation and IPC
Educator in-depth interviews 16 randomly-selected educators at
12 months of intervention across sites
Educator reflective journals All educators, monthly, up to 2 years
of intervention
MDET debriefing sessions All educators, quarterly, up to
2 years of intervention
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open-ended questions. Individual scores will be aggre-
gated to create an understanding of the overall team func-
tioning at each site. The tool will be administered to PCPs
and MDET educators after 12 months of the intervention.
Qualitative data collection
Qualitative process data will be collected to describe
how the intervention unfolds in practice and to assess
the reliability of implementing the intervention across
sites. The MDETs will be asked to record field notes of
their experiences with the intervention, including their
collaborations with PCPs, in a reflective journal. Quar-
terly debriefing sessions with the MDETs to discuss im-
plementation issues that arise during the intervention
period will be recorded, transcribed and analyzed for
emergent themes, such as communication, shared deci-
sion making and so on.
In addition, purposively selected patients [44], MDET
educators and PCPs will be asked to participate in a 45-
to 60-minute open-ended qualitative face-to-face or tele-
phone interview after 12 months from the start of the
intervention. Potential participants will be stratified by
sites, then invited to participate in an interview in order
to ensure representation from all sites involved in the
trial (maximum variation sampling) [45]. To obtain sat-
uration for a heterogeneous group, interviews are
planned with 15 to 20 people representing each group of
patients, PCPs and educators who have participated in
the MDET intervention. We will interview participants
until saturation has been achieved (that is, when no new
themes are being generated). Patient interview questions
will pertain to how useful the intervention was in terms
of better understanding their condition, diabetes self-
management strategies, and the convenience and quality
of delivery. Both MDETs and PCPs will be asked ques-
tions about their experiences with the intervention, their
collaboration and teamwork, barriers and facilitators to
implementation, and suggestions to improve the inter-
vention. Participants will be compensated for their time.
All interview questions will be piloted on two patients,
PCPs and diabetes educators prior to interviews.
Statistical analysis
All sites will eventually receive the MDET intervention
on an ongoing basis following the stepped wedge design,
which allows us to evaluate the intervention effect utiliz-
ing both within- and between-site information while
controlling for underlying time trends (for example,
Hussey et al., 2007) [46]. We plan to sample 20 unique
patients/charts per site per time period (1,200 in total),
based on the primary hypothesis of a greater proportion
of patients reaching the clinically recommended target
(HbA1C ≤7%). The proposed sample size will give riseto over 80% power at a significance level of 1% (adjust-
ing for multiple testing) assuming the between-site vari-
ation in terms of the coefficient of variation is 0.8. The
minimal detectable effect size (expressed as a relative
risk) based on the proposed sample is as small as 18%,
for baseline proportions “p” in the range of 0.3 to 0.6 (as
reported in McCrate et al., 2010 [47], Harris et al., 2005
[7] and Borgermans et al., 2009 [15]]. For example, con-
sidering a conservative baseline proportion of P= 0.5
and an intraclass correlation (correlation between
patients from the same site) of 0.39, we will have 80%
power to detect a relative change in proportion of 18%
(that is, from 0.5 to 0.59 ((0.59 to 0.5)/0.5 = 0.09/
0.5 = 0.18)) attributed to the intervention over a six-
month period. We will assess the sample size at the end
of the 12 months, and if necessary, the sample size esti-
mation will be adjusted according to established methods
described in Chen et al. 2004 [48].
Quantitative data analysis
Specifically, for Objective #1, we will test the effective-
ness of the MDET intervention on clinical outcomes
(for example, HbA1C≤ 7%, LDL-C <2.0 mmol/L) using
the generalized linear mixed models (GLMM), which in-
clude site as the random effect, time as a fixed effect and
the intervention effect. With the GLMM approach, the
temporal trends in the effect of the intervention are also
evaluated, while the correlations between patients within
the same site as well as the variations between sites are
accounted for (Hussey et al., 2007) [46]. The patient-
level covariates (for example, age, sex, duration living
with diabetes, smoking status) and PCP-level (within
sites) covariates (for example, years of practice) will also
be included in the model. Hierarchical linear models
(HLM) [49,50] are an important special case of GLMM,
and the former name is more commonly seen in the lit-
erature for nested data structures (for example, patients
at Level 1, PCPs at Level 2 and sites at Level 3). GLMM
will facilitate modeling all three level variances in patient
outcomes, while utilizing patient variables at Level 1,
PCP variables at Level 2 and site variables at Level 3. In
addition, we will consider the generalized estimating
equations (GEE) approach, which has been suggested to
be more robust to misspecification of the variance struc-
ture (including. correlations between patients within
sites) (Hussey et al., 2007) [46]. For Objective #2, we will
evaluate the effect of the MDET intervention on quality
of care delivered to patients (for example, screening for
ACR and eGFR) using the GLMM approach, as
described for Objective #1, in addition to descriptive
summaries (for example, for change in drug dose, PCP
years practicing). GLMM will also be used to assess the
intervention effect on, for example, the referral rate to
DEPs under Objective #3, where the PCPs form the unit
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sites will be taken into account along with the temporal
trends of the MDET effects.
For the analyses described above, overall Type I error
will be set to 1% (instead of 5%) for all calculations of con-
fidence intervals and for testing the various hypotheses, in
order to account for the possible occurrence of false posi-
tives due to “multiple testing” (increased chance of finding
statistical significance beyond the nominal significance
level). Model diagnostic tools and cross-validation methods
will be considered for model assessment. Since missing
values are unavoidable, these values will be handled with
extra caution. Reasons and mechanisms for the missing
data points will be explored by various summary statistics
as well as graphical displays. Appropriate statistical techni-
ques to handle missing values will be further explored and
taken into account in the proposed statistical modeling
[51], (including imputation of missing data). Statistical ana-
lyses will be carried out using the statistical software
packages SAS (V9.2) (SAS Institute Inc., Cary, North Caro-
lina, USA), and R (V2.12) (GNU Operating System, open
source).
Qualitative data analysis
All qualitative data collected will be analyzed by the-
matic analysis using a reciprocal coding approach
[45,52], where researchers engage in open dialogue
about themes and data interpretation. The theoretical
framework underpinning the qualitative analysis is con-
structivist insofar as interpretation will take into account
the multiplicities of views informing participants’ experi-
ences [53]. Transcripts (that is, from field notes, debrief-
ing sessions and interviews) will be first reviewed
independently, and then through dialogue, and compos-
ite themes will be developed by at least two researchers.
Thematic analysis, or pattern coding, is a method for
grouping diverse sections of data into smaller analytic
units [54]. A coding framework will be developed.
MaxQDA Plus software (VERBI GmbH, Charlottenburg,
Berlin, Germany) will be used to manage data and per-
form analysis. Preliminary findings will be shared with
healthcare professionals to support the rigor and authen-
ticity of the study findings.
Discussion
We assume that the increasing prevalence of diabetes,
combined with its complexity, rapidly evolving medical
therapies and the requirement for patient self-management
will lead to a growing demand for shared care across disci-
plines that target improvements in diabetes care and man-
agement [55]. We believe this model of care has the
potential to improve professional practice and patient out-
comes in diabetes care in our trial but also across Canada.
In addition to strengthening and formalizing links betweenPCPs and DEPs, we expect that MDETs in primary care
can increase timely access to DSMS, training and support,
and improve patient experience and clinical outcomes
through enhanced coordination and integration of care.
The creation of inter-professional teams in primary care
will provide a knowledge exchange opportunity by men-
toring and developing diabetes proficiency in PCPs to im-
prove knowledge and confidence in managing patients
with diabetes and to refer more complex patients to spe-
cialized care.
This study is timely and relevant as DEPs and local
PCPs are starting to integrate services across Canada to
provide more team-based care to rectify the existing
health service gaps demonstrated in the Canadian litera-
ture; thus, our research will provide health service policy
makers with the necessary evidence to inform the practice
of such a model in primary care. If MDETs are found to
be feasible and effective, this alternative primary care
model can be extended to other diabetes-related popula-
tions, such as those with impaired glucose tolerance and
gestational diabetes/post-gestational diabetes. This MDET
intervention can direct how diabetes prevention, manage-
ment and care are delivered within primary care practice,
and greatly reduce the burden of diabetes.
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